SARS-CoV-2
- Health
Study explains why Covid virus affects smell and taste
New York: SARS-CoV-2, the virus causing Covid-19, can infect sensory neurons explaining why many people reported losing their senses of smell and taste, finds a study. When Covid-19 began spreading in 2020,…
- Health
Covid variants can evolve 3x faster in deer than in humans: Study
New York: Covid-19 viral variants can evolve about three times faster in deer than in humans, according to a study that documented at least 30 Covid infections in white-tailed deer in the…
- Health
Amid detection of new Covid variants, PMO calls for regular monitoring
New Delhi: Amid the detection of certain new variants of SARS-CoV-2 virus reported globally, senior officials of the Prime Minister’s Office (PMO) on Monday held a review meeting to take stock of…
- Health
Pre-Covid Vaccination cuts post-infection deaths by 60%: ICMR Study
New Delhi: Covid vaccination before SARS-CoV-2 virus infection prevented 60 per cent post-infection deaths in India, according to a study led by the Indian Council of Medical Research (ICMR). A team from…
- Health
This is how coronavirus jump from species to species
New Delhi: Throughout the pandemic, there has been much discussion of how Covid-19 infiltrates cells by hijacking a protein called ACE2 found on human cells. However, new research has revealed that ACE2…
- Health
About 5% of new diabetes cases linked to Covid: Study
Toronto: Nearly 3-5 per cent cases of onset of diabetes is due to Covid-19, in other words roughly one person in 20 is a diabetic, according to an alarming study. The study,…
- Health
New method for early detection of SARS-CoV-2 infection
New Delhi: A new sandwich-based lateral flow immunoassay (LFIA) for the detection of Receptor Binding Domain (RBD) of severe acute respiratory syndrome-coronavirus-2 (SARS-CoV-2) could provide an efficient substitute for RT-PCR tests. According…
- World
Study reveals potential Covid-19 cases in Germany in Dec 2019
Berlin: Researchers have confirmed that a 71-year-old man from Germany was suffering from Covid-19 disease in December 2019. China made Covid-19 disease official on December 31, 2019. However, a day before doctors…
- Health
How a SARS-CoV-2 virus protein damages the heart, study finds
Washington: Scientists have identified the mechanism behind how SARS-CoV-2 virus damages the heart tissue. People infected with COVID-19 are at a significantly higher risk for developing inflammation of the heart muscle, abnormal…
- Health
BCG vaccine for tuberculosis protects diabetics from COVID-19: Study
Boston: A widely used tuberculosis vaccine protected people with Type 1 diabetes from COVID-19, according to a study that demonstrates the potential of multiple doses of the Bacillus Calmette-Guerin (BCG) preventive against…
- India
Study confirms airborne transmission of coronavirus
Hyderabad: A collaborative study by a group of scientists from the CSIR-CCMB, Hyderabad and the CSIR-IMTech, Chandigarh, with hospitals in Hyderabad and Mohali has confirmed the airborne transmission of SARS-CoV-2. The study…
- Health
How placenta blocks Covid transmission to babies during pregnancy
New York: While Covid-19 disease significantly impacts many pregnant women, the rates of transmission from mother to baby in pregnancy are very low. A new study from Boston University School of Medicine…
- India
Two years on, India’s battle with COVID-19, its variants continues with no end in sight
New Delhi: Amid the third wave of the COVID-19 pandemic, India has completed two years since the first coronavirus case was reported in the country and during this time, it has not…
- Telangana
Telangana records 2702 new COVID-19 cases
Telangana recorded a surge in the daily COVID-19 cases, on Thursday, with 2702 new infections being reported, taking the tally to 7,02,801, while the death toll rose to 4049 with two cases…
- World
Multivariant Covid vaccine booster shows promise, early data suggests
London: A COVID-19 vaccine booster aimed at tackling multiple coronavirus variants shows promise in inducing a comprehensive immune response, early data suggests. The initial phase one clinical data shows the vaccine has strong…
- 1
- 2